Cibus
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | <1m | 7.3m | 23.9m | 26.0m | <1m | 1.8m | 2.5m |
% growth | (54 %) | 2992 % | 227 % | 9 % | (99 %) | 1057 % | 38 % |
EBITDA | (25.6m) | (36.5m) | (40.6m) | (28.5m) | (22.4m) | (64.6m) | - |
% EBITDA margin | (10830 %) | (500 %) | (170 %) | (110 %) | (14248 %) | (3557 %) | - |
Profit | (27.9m) | (39.6m) | (44.8m) | (29.2m) | (16.9m) | (268m) | - |
% profit margin | (11821 %) | (543 %) | (188 %) | (112 %) | (10759 %) | (14729 %) | - |
R&D budget | 10.4m | 12.2m | 11.1m | 11.3m | 11.6m | 42.4m | - |
R&D % of revenue | 4389 % | 167 % | 46 % | 44 % | 7359 % | 2332 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $4.3m | Series A | |
N/A | $57.0m | Series B | |
$70.0m | Series C | ||
* | N/A | N/A | IPO |
* | N/A | $20.3m | Post IPO Equity |
* | N/A | $13.0m | Post IPO Equity |
* | N/A | $12.0m | Post IPO Equity |
Total Funding | €119m |
Related Content
Recent News about Cibus
EditCibus is a pioneering company in the agricultural biotechnology sector, specializing in the development of non-GMO (non-genetically modified organism) plant traits. The company leverages its proprietary precision gene editing technology, RTDS (Rapid Trait Development System), to introduce desirable characteristics into crops much faster than traditional breeding methods. These traits include herbicide tolerance, disease resistance, and improved nutritional profiles, aimed at meeting the demands of farmers and enhancing human health. Cibus operates in the global agricultural market, serving farmers, seed developers, and the broader agricultural community. The company's business model involves both the direct deployment of these traits into its own products and collaborations with seed developers to integrate these traits into a variety of crops. Revenue is generated through the commercialization of these enhanced crops and partnerships with other agricultural entities. Currently, Cibus is nearing the commercial rollout of its weed tolerance traits in flax and rice and is developing traits for wheat, soybean, and corn. The company's mission is to innovate for a sustainable future by improving crop productivity, enhancing food health and nutrition, and protecting the planet by growing healthier food with fewer resources.
Keywords: non-GMO, gene editing, RTDS, herbicide tolerance, disease resistance, nutritional enhancement, crop yield, agricultural biotechnology, sustainable farming, seed development.